NCT06825013View on ClinicalTrials.gov

Bronchodilators and Lung Mechanics During Exercise in COPD

PHASE4RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 10, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
COPD
Interventions
DRUG

Bronchodilators inhalation

Salbutamol sulphate (2.5 mg) + ipratropium bromide (0.5 mg)

DRUG

Placebo

Nebulized saline

Trial Locations (1)

K7L 2V6

RECRUITING

Respiratory Investigation Unit, Kingston Health Sciences Center, Kingston

All Listed Sponsors
lead

Dr. J. Alberto Neder

OTHER

NCT06825013 - Bronchodilators and Lung Mechanics During Exercise in COPD | Biotech Hunter | Biotech Hunter